Mr. Mahoney became CEO of Boston Scientific in 2012 and became board chair in 2016. His career includes more than 25 years of building market-leading medical device, capital equipment and health care IT businesses. Prior to Boston Scientific, Mr. Mahoney served as worldwide chairman of Johnson & Johnson’s medical devices and diagnostics division.
“Mike’s focus throughout his career — to drive improvements in health outcomes and increase access to care — align with our mission at CVS Health,” Karen Lynch, president and CEO, said. “Adding a well-respected health care leader to our board demonstrates our continued focus on strengthening our engagement with consumers to improve their health and well-being.”
CVS Health’s board on Sept. 21 approved a quarterly dividend of $0.605 cents per share on the common stock of the corporation. The dividend is payable on Nov. 1 to holders of record on Oct. 20.
